ARTICLE | Clinical News
AVR118: Phase II start
September 10, 2007 7:00 AM UTC
ADVR plans to start a Phase II trial of AVR118 in 14 cancer patients with cachexia-related symptoms. Pending the results from this first cohort, the trial could enroll at least 32 patients. ...